Teletherapy for subfoveal choroidal neovascularisation of age-related macular degeneration: Results of follow up in a non-randomised study

British Journal of Ophthalmology

Volumn 80, Issue 12, 1996, Pages 1046-1050

  Hart, P M ^a   Chakravarthy, U ^a   MacKenzie, G ^a   Archer, D B ^a   Houston, R F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RETINA MACULA DEGENERATION; RETINOPATHY; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY;

EID: 0030475505     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.12.1046     Document Type: Article

References (25)

1. Kahn HA, Moorehead HB. Statistics on blindness in the model reporting area 1969-1970. United States Department of Health, Education and Welfare Publication No (NIH) 73-427. Washington DC: US Government Printing Office, 1973.
2. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three year results from randomized clinical trials. Arch Ophthalmol 1986;104:694-701.
3. Bird AC. Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol 1974;58:367-76.
4. Bressler NM, Bressler SB, Gragoudas EG. Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol 1987;105:209-31
5. Rodger FC. Some practical conclusions following a longitudinal study of common macular lesions. Trans Ophthalmol Soc UK 1982;102:187-97
6. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Arch Ophthalmol 1991;109:1220-31.
7. Moisseiev, J, Ahalel A, Masuri R, Treister G. The impact of macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995;113:183-9.
8. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993;77:265-73.
9. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 1976;120:167-71.
10. Tanner M. Tools for statistical inference. Hayword: IMS, 1991.
11. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for sub-foveal choroidal neovascularisation secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-8.
12. Gillies MC, Sarks JP, Beaumont PE, Hunyor AB, McKay D, Kearns M, et al. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b. Br J Ophthalmol 1993;77:759-65.
13. Kirkpatrick JNP, Dick AD, Forrester JV. Clinical experience with interferon alfa 2a for exudative age-related macular degeneration. Br J Ophthalmol 1993;77:766-70.
14. Tang Y. Interferon friend or foe. Arch Ophthalmol 1995;113: 987.
15. Guyer DR. Experimental therapies for exudative age-related macular degeneration. American Academy Abstracts 1995: 60-7.
16. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-68.
17. Berger AS, Kaplan AG. Clinical experience with the surgical removal of sub-foveal neovascular membranes. Ophthalmology 1992;99:969-76.
18. Bergink GJ, Deutman AF, van den Broek JFCN, van der Maazen RWM. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1994;232:591-8.
19. Bergink GJ, Deutman AF, van den Broek JE, van Daal WA, van der Maazen RM. Radiation therapy for age-related subfoveal choroidal neovascular membranes. A pilot study. Doc Ophthalmol 1995;90:67-74.
20. Friedrichsen EJ, SlaterJD, Loredo LN, Yonemoto LT, Inj JJ, Garcia CA, et al. Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration. Invest Ophthalmol Vis Sci 1995;36(suppl):1020.
21. Immonen I, Jakkola A, Heikkonen J. Treatment of subfoveal choroidal neovascular membranes using strontium 90 plaques irradiation. Invest Ophthalmol Vis Sci 1995; 36(suppl):1022.
22. Finger PT. Radiotherapy for subretinal neovascularisation. Invest Ophthalmol Vis Sci 1995;36(suppl):1021.
23. Aristizibal S, Caldwell WK, Avilla J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Biol Phys 1977;2:667-73.
24. Wara W, Irvine AR, Neger RE, Howes EL, Phillips TL. Radiation retinopathy. Int J Radiat Biol Phys 1979;5:81-3.
25. Miller ML, Goldberg SH, Bullock JD. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol 1991;112:600-1.